STAR.NS Earnings Date: Oct 30, 2026 — Strides Pharma Science Limited

NSE

Updated Oct 30, 2026

Price —

Market Cap $92.1B

P/E 15.5

52W Range — – —

Next Earnings Oct 30, 2026

When is STAR.NS's next earnings date?

Strides Pharma Science Limited (STAR.NS) is scheduled to report earnings on Friday, October 30, 2026. The consensus estimate is revenue of $14.15B.

How did STAR.NS do in its last earnings report?

In its most recent report on Jul 31, 2026, Strides Pharma Science Limited posted EPS of $17.00. Revenue was $12.73B against a $13.32B estimate.

About Strides Pharma Science Limited

Strides Pharma Science Limited is a pharmaceutical company that focuses on the development, production, and worldwide commercialization of medicinal products. Its extensive global footprint spans Africa, Australia, North America, Europe, Asia, India, and various other international markets. The company's operations are structured into two distinct segments: Pharmaceutical and Biopharmaceutical. It provides a diverse range of generic pharmaceuticals, available in multiple formats including tablets, hard and soft gelatin capsules, sachets, liquids, nasal sprays, powders, solids, ointments, and creams. Furthermore, Strides Pharma Science creates branded generic offerings for treating chronic ailments such as women's health issues, central nervous system disorders, cardiovascular conditions, diabetes, dermatological concerns, and probiotic support, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. For institutional business, the company supplies drugs targeting infectious diseases, including anti-retrovirals, anti-malarials, anti-tuberculosis, and Hepatitis treatments. Incorporated in 1990, the company is headquartered in Bengaluru, India. It was formerly known as Strides Shasun Limited before adopting its current name in July 2018.

🤖 AI Earnings Analysis

STAR.NS trades at 15.5× earnings with an 11.45% profit margin, suggesting moderate valuation but leaving profitability central to the investment case.

AI-generated summary — powered by BigEarnings.